NINDS invites applications for research leading to drug discovery for nervous system disorders. This announcement is made together with 4 other NIH components.
Significant advances in neuroscience, genetics, and behavioral science—together with technological developments—have provided a rich knowledge for understanding pathophysiology, identifying new targets for drug discovery, and developing pharmacotherapies for the treatment of many nervous system disorders. The objective of this initiative is to stimulate research in the discovery, design, and preclinical testing of novel therapeutics aimed at prevention or treatment of nervous system disorders.
Potential applicants should contact Dr. Mark Scheideler, program director, Office of Translational Research, NINDS; telephone: 301-496-1779; email: email@example.com. For more information visit http://grants.nih.gov/grants/guide/pa-files/PAR-10-001.html.